| White Mountain Eye Institute Plc | |
| 39 E 1st St, Eagar, Arizona 85925 | |
| (928) 333-4396 |
| Name | White Mountain Eye Institute Plc |
|---|---|
| Organization Name | White Mountain Eye Institute Plc |
| Location | 39 E 1st St, Eagar, Arizona 85925 |
| Type | Supplier |
| Phone | (928) 333-4396 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
New research supports the findings of a landmark drug comparison study published in 2002 in which a diuretic drug or "water pill" outperformed other medications for high blood pressure. A scientific team including investigators from The University of Texas Health Science Center at Houston reports the findings in the May 11 issue of the Archives of Internal Medicine.
In 2017 a paper was published asserting that intravenous vitamin C given to patients with sepsis was literally a life saver. Despite the study only looking at 47 subjects the results garnered international coverage and was adopted in many ICUs worldwide.
BNA Books, a division of BNA, announces the publication of the Second Edition of Pharmaceutical Patent Law, the most relied upon reference available with a detailed, practitioner-oriented treatment of pharmaceutical patent law from the perspective of both patent law and the food and drug laws.
Gilead Sciences, Inc. today announced that the company's Marketing Authorisation Application for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus infection, which was submitted to the European Medicines Agency on April 17, 2013, has been fully validated and is now under assessment.
Preventive cardiology is now on the political as well as clinical agenda. In 2011 a UN heads-of-state meeting agreed to reduce mortality from chronic non-communicable diseases by 25% by 2025.
› Verified 5 days ago
News Archive
New research supports the findings of a landmark drug comparison study published in 2002 in which a diuretic drug or "water pill" outperformed other medications for high blood pressure. A scientific team including investigators from The University of Texas Health Science Center at Houston reports the findings in the May 11 issue of the Archives of Internal Medicine.
In 2017 a paper was published asserting that intravenous vitamin C given to patients with sepsis was literally a life saver. Despite the study only looking at 47 subjects the results garnered international coverage and was adopted in many ICUs worldwide.
BNA Books, a division of BNA, announces the publication of the Second Edition of Pharmaceutical Patent Law, the most relied upon reference available with a detailed, practitioner-oriented treatment of pharmaceutical patent law from the perspective of both patent law and the food and drug laws.
Gilead Sciences, Inc. today announced that the company's Marketing Authorisation Application for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus infection, which was submitted to the European Medicines Agency on April 17, 2013, has been fully validated and is now under assessment.
Preventive cardiology is now on the political as well as clinical agenda. In 2011 a UN heads-of-state meeting agreed to reduce mortality from chronic non-communicable diseases by 25% by 2025.
› Verified 5 days ago
White Mountain Eye Institute Plc Type: Medicare Supplier Location: 39 E 1st St, Eagar, Arizona 85925 Phone: (928) 333-4396 |